New Strategies in Drug Development Focusing on the Anti-Protease-Protease Balance in Alpha-1 Antitrypsin Deficiency

E-ISSN： 1875-614x|9|4|314-329

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.9, Iss.4, 2010-12, pp. : 314-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alpha-1-Antitrypsin Deficiency Liver Disease and New Treatment Opportunities

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 5, 1970-01 ,pp. : 382-391

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for alpha-1-antitrypsin deficiency

By Stockley Robert A

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 685-694

Informa Healthcare

Access to resources Recommend Favorite

Alpha-1-Antitrypsin Deficiency and Mechanisms of Liver Disease

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 4, 2010-12 ,pp. : 289-298

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Alpha1-Antitrypsin Deficiency in Respiratory Disease

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 4, 2010-12 ,pp. : 299-303

Bentham Science Publishers

Access to resources Recommend Favorite

Protease-mediated signalling: new paradigms for cell regulation and drug development

By Hollenberg M.D.

Trends in Pharmacological Sciences, Vol. 17, Iss. 1, 1996-01 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite